EvolveImmune Therapeutics
Richard Flavell is a scientific advisor at EvolveImmune Therapeutics. Richard was previously the CSO at Biogen from January 1982 to December 1988. Richard has also worked as a professor at Yale University and as a researcher at the Howard Hughes Medical Institute. Richard Flavell is a renowned immunologist and their research has led to breakthroughs in our understanding of the immune system.
This person is not in the org chart
This person is not in any offices
EvolveImmune Therapeutics
2 followers
EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT. Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.